Characterization of three sialidases from Danio rerio.

Aggregation in solution In silico gene expression Molecular modelling Recombinant sialidases Substrate specificities

Journal

Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 30 12 2020
revised: 05 05 2021
accepted: 12 05 2021
pubmed: 23 5 2021
medline: 6 8 2021
entrez: 22 5 2021
Statut: ppublish

Résumé

Zebrafish encodes several sialidases belonging to the NEU3 group, the plasma membrane-associated member of the family with high specificity toward ganglioside substrates. Neu3.1, Neu3.2 and Neu 3.3 have been expressed in E. coli and purified using the pGEX-2T expression system. Although all the enzymes are expressed by bacterial cells, Neu3.1 formed insoluble aggregates that hampered its purification. Neu3.2 and Neu3.3 formed oligomers as demonstrated by gel filtration chromatography experiments. Actually, the first formed a trimer whereas the second a pentamer. Intriguingly, despite relevant degree of sequence identity and similarity, the two enzymes showed peculiar substrate specificities toward gangliosides other than GM3, two glycoproteins and two forms of sialyllactose. Using molecular modelling and the crystal structure of the human cytosolic sialidase NEU2 as a template, the 3D models of the sialidases from zebrafish have been generated. As expected, the 3D models showed the typical six blade beta-propeller typical of sialidases, with an overall highly conserved active site architecture. The differences among the three zebrafish enzymes and human NEU2 are mainly located in the loops connecting the antiparallel beta strands of the propeller core. These portions of the proteins are probably responsible for the differences observed in substrate specificities, as well as in the different subcellular localization and aggregation features observed in solution. Finally, the in silico analysis of RNA-Seq data evidenced a peculiar expression profile of the three genes during embryogenesis, suggesting different roles of these sialidases during development.

Identifiants

pubmed: 34022291
pii: S0300-9084(21)00123-1
doi: 10.1016/j.biochi.2021.05.005
pii:
doi:

Substances chimiques

Recombinant Proteins 0
Zebrafish Proteins 0
Neuraminidase EC 3.2.1.18

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-66

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Matilde Forcella (M)

Dept. of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.

Marta Manzoni (M)

Division of Biotechnology, Dept. of Molecular and Translational Medicine (DMTM), University of Brescia, Brescia, Italy.

Giuliana Benaglia (G)

Division of Biotechnology, Dept. of Molecular and Translational Medicine (DMTM), University of Brescia, Brescia, Italy.

Marcella Bonanomi (M)

Dept. of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.

Edoardo Giacopuzzi (E)

National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.

Nadia Papini (N)

Dept. of Medical Biotechnology and Translational Medicine, University of Milano, Italy.

Roberto Bresciani (R)

Division of Biotechnology, Dept. of Molecular and Translational Medicine (DMTM), University of Brescia, Brescia, Italy.

Paola Fusi (P)

Dept. of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.

Giuseppe Borsani (G)

Division of Biology and Genetics, Dept. of Molecular and Translational Medicine (DMTM), University of Brescia, Brescia, Italy.

Eugenio Monti (E)

Division of Biotechnology, Dept. of Molecular and Translational Medicine (DMTM), University of Brescia, Brescia, Italy. Electronic address: eugenio.monti@unibs.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH